AGENT FOR TREATMENT OF MYELOFIBROSIS

PROBLEM TO BE SOLVED: To provide a new agent for treatment of myelofibrosis. SOLUTION: There are provided a substance transfer carrier for an extracellular matrix production cell in bone marrow containing a retinoid, and the agent for treatment of myelofibrosis using a drug to control activity or pr...

Full description

Saved in:
Bibliographic Details
Main Authors MATSUNAGA TAKUYA, NIITSU YOJIRO
Format Patent
LanguageEnglish
Published 18.03.2010
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide a new agent for treatment of myelofibrosis. SOLUTION: There are provided a substance transfer carrier for an extracellular matrix production cell in bone marrow containing a retinoid, and the agent for treatment of myelofibrosis using a drug to control activity or proliferation of the extracellular matrix production cell in the bone marrow. COPYRIGHT: (C)2010,JPO&INPIT
Bibliography:Application Number: JP20080228338